SCHEMBL20655372

SCHEMBL20655372

N#Cc1ccccc1-c1ccc2c3ccccc3n(-c3ccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc3-c3cc(-c4ccccc4)nc(-c4ccccc4)n3)c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRG2 P18507 3/20 0.38
GABRB3 P28472 3/20 0.38
GABRA5 P31644 2/20 0.38
GABRA3 P34903 2/20 0.38
TRPA1 O75762 1/20 0.37
ALDH1A1 P00352 5/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
HPGD P15428 3/20 0.36
MAPT P10636 2/20 0.36
NR3C1 P04150 1/20 0.35
NTSR1 P30989 1/20 0.34
ALOX5AP P20292 1/20 0.34
FEN1 P39748 1/20 0.34
MGLL Q99685 1/20 0.34
MAOB P27338 2/20 0.33
LMNA P02545 2/20 0.33
KDM4E B2RXH2 1/20 0.33
GLA P06280 1/20 0.33
MAOA P21397 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20655167 0.99 GABRG2 (0.39) GABRG2GABRB3GABRA5GABRA3TRPA1
SCHEMBL20655253 0.97 GABRG2 (0.39) GABRG2GABRB3GABRA5GABRA3TRPA1
SCHEMBL20655152 0.97 GABRG2 (0.40) GABRG2GABRB3GABRA5GABRA3TRPA1
SCHEMBL20655290 0.96 GABRG2 (0.38) GABRG2GABRB3GABRA5GABRA3TRPA1
SCHEMBL20654971 0.96 GABRG2 (0.38) GABRG2GABRB3GABRA5GABRA3TRPA1
SCHEMBL20655643 0.96 GABRG2 (0.41) GABRG2GABRB3GABRA5GABRA3TRPA1
SCHEMBL20655559 0.94 GABRG2 (0.38) GABRG2GABRB3GABRA5GABRA3TRPA1
SCHEMBL20655151 0.94 GABRG2 (0.38) GABRG2GABRB3GABRA5GABRA3TRPA1
SCHEMBL20655453 0.94 GABRG2 (0.40) GABRG2GABRB3GABRA5GABRA3TRPA1
SCHEMBL20655274 0.94 GABRG2 (0.41) GABRG2GABRB3GABRA5GABRA3TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11005048-B2 Organic molecules, in particular for use in optoelectronic devices CYNORA GMBH (DE) 2021-05-11 US disclosed
EP-3530659-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-08-28 EP disclosed
EP-3431473-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-01-23 EP disclosed
US-20190019960-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190019960-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OR51E2, ORC3 GABRG2 2954/4885GABRB3 2027/4885GABRA5 3627/4885
US-11005048-B2 Organic molecules, in particular for use in optoelectronic devices OR10J3, OR51E2, ORC3 GABRG2 2954/4885GABRB3 2027/4885GABRA5 3627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.